Northside Hospital Cancer Institute — Atlanta, Georgia

Northside Hospital Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30341.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Northside Hospital Cancer Institute has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Melanoma, Multiple Myeloma, Hormone Receptor Positive Breast Cancer.

Sponsors: Elios Therapeutics, LLC, Janssen Scientific Affairs, LLC, Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital Cancer Institute?

Northside Hospital Cancer Institute has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital Cancer Institute conducted?

Northside Hospital Cancer Institute has 9 clinical trials on record, with 3 currently active. Their work covers Melanoma, Multiple Myeloma, Hormone Receptor Positive Breast Cancer.

Is Northside Hospital Cancer Institute accredited by Crixeo Health?

Yes — Northside Hospital Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Northside Hospital Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.